Dominic Carrano is the Chief Financial Officer (CFO) of Veradermics, with over 15 years of experience in financial leadership, technical accounting, and strategic planning in the life sciences sector. He leads the company’s financial strategy and operations to support growth and execution.

Prior to becoming CFO, Mr. Carrano served as Vice President of Finance at Veradermics, where he oversaw financial operations and financing activities. Before that, he was Vice President of Finance and Controller at Rallybio Corporation, where he led financial operations and played a key role in the company’s IPO execution, follow-on offering, and ongoing SEC compliance.

Mr. Carrano began his career at Deloitte & Touche LLP and later held financial leadership roles at Alexion Pharmaceuticals, focusing on SEC reporting and technical accounting.

He holds both a MS and a BS in Accounting from the University of Connecticut and is a Certified Public Accountant.